Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jun 2023 for Hikma Pharmaceuticals PLC, €32k.
Filing timeline
BuySaleDouglas Hurt
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +2.5%Entry £18.83 · Close at T+365 £19.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Douglas Hurt: trading record in brief
Only one filing by Douglas Hurt is known so far (8 June 2023): an open-market purchase, €32k, in Hikma Pharmaceuticals PLC. That is too little to draw conclusions. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Douglas Hurt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 0100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:4796506Canonical exit: 4 Sept 2023 (T+90)
1 of 1 declaration